Article info

Download PDFPDF
Genomic aberrations and immunohistochemical markers as prognostic indicators in multiple myeloma
  1. Dr Hong Chang, Department of Laboratory Hematology, Toronto General Hospital, University Health Network, 200 Elizabeth Street, 11E-413, Toronto, ON, Canada M5G 2C4; hong.chang{at}uhn.on.ca
View Full Text

Citation

Yeung J, Chang H
Genomic aberrations and immunohistochemical markers as prognostic indicators in multiple myeloma

Publication history

  • Accepted November 22, 2007
  • First published December 12, 2007.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.